Open access
Open access
Powered by Google Translator Translator

Geriatrics

Systematic Review | There is little evidence to guide interventions for preventing and reducing the use of physical restraints on older people in general hospital settings.

29 Aug, 2022 | 12:01h | UTC

Interventions for preventing and reducing the use of physical restraints of older people in general hospital settings – Cochrane Library

 


Update on the management of diabetes in long-term care facilities.

26 Aug, 2022 | 13:23h | UTC

Update on the management of diabetes in long-term care facilities – BMJ Open Diabetes Research & Care

 


Scoping review of randomized trials with discontinuation of medicines in older adults.

26 Aug, 2022 | 13:16h | UTC

Scoping Review of Randomized Trials With Discontinuation of Medicines in Older Adults – JAMDA

 


Systematic Review | Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia.

24 Aug, 2022 | 14:10h | UTC

Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia – Cochrane Library

Summary: The impact of cumulative medications with anticholinergic effects on future adverse clinical outcomes in people with dementia – Cochrane Library

Related:

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Commonly-prescribed drugs and dementia: should we be worried? – Evidently Cochrane

Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome – Cochrane Library

Anticholinergic drugs and dementia: time for transparency in the face of uncertainty – Cochrane Library

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study – JAMA Internal Medicine

How well do you know your anticholinergic (antimuscarinic) drugs? – Therapeutics Initiative

Anticholinergic drugs and risk of dementia: case-control study – The BMJ

 


Review | Neurosurgical enhanced recovery after surgery for geriatric patients undergoing elective craniotomy.

22 Aug, 2022 | 12:05h | UTC

Neurosurgical enhanced recovery after surgery ERAS for geriatric patients undergoing elective craniotomy: A review – Medicine

Related:

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

 


Launch of first WHO position paper on optimizing brain health across life.

17 Aug, 2022 | 14:41h | UTC

News Release: Launch of first WHO position paper on optimizing brain health across life – World Health Organization

WHO position paper: Optimizing brain health across the life course – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


Talking about dying: better conversations at the end of life.

17 Aug, 2022 | 14:14h | UTC

Talking about dying: better conversations at the end of life – Evidently Cochrane

Original Reviews:

Interventions for interpersonal communication about end of life care between health practitioners and affected people – Cochrane Library

Communicating with patients and families about illness progression and end of life: a review of studies using direct observation of clinical practice – BMC Palliative Care

 

Commentary on Twitter

 


Study suggests long covid symptoms affect 1 in 8 patients.

16 Aug, 2022 | 13:52h | UTC

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study – The Lancet

News Release: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet

Commentaries:

Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP

Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ

 


Probability of males to outlive females: an international comparison from 1751 to 2020.

16 Aug, 2022 | 13:33h | UTC

Probability of males to outlive females: an international comparison from 1751 to 2020 – BMJ Open

News Release: Men have high probability of outliving women, especially if married and degree educated – BMJ Newsroom

 


M-A | Effect of regional anesthesia on postoperative delirium.

16 Aug, 2022 | 13:08h | UTC

Effect of regional anesthesia on the postoperative delirium: A systematic review and meta-analysis of randomized controlled trials – Frontiers in Surgery

 


The influence of pregnancy, parity, and mode of delivery on urinary incontinence and prolapse surgery – a national register study.

12 Aug, 2022 | 14:36h | UTC

The influence of pregnancy, parity, and mode of delivery on urinary incontinence and prolapse surgery – a national register study – American Journal of Gynecology & Obstetrics

 


RCT | In older patients undergoing total intravenous anesthesia, Etomidate is noninferior to Propofol regarding the risk of major postoperative complications.

11 Aug, 2022 | 12:18h | UTC

Effect of Etomidate vs Propofol for Total Intravenous Anesthesia on Major Postoperative Complications in Older Patients: A Randomized Clinical Trial – JAMA Surgery

 

Commentary on Twitter

 


Trauma care in older people: charting a path from outlier to excellence.

11 Aug, 2022 | 12:16h | UTC

Trauma care in older people: charting a path from outlier to excellence – Age and Ageing

 


Is the contemporary care of older persons with acute coronary syndrome evidence-based?

8 Aug, 2022 | 11:48h | UTC

Is the contemporary care of the older persons with acute coronary syndrome evidence-based? – European Heart Journal Open

 

Commentary from the author on Twitter

 


Cross-Sectional Study | Experiences of everyday ageism and the health of older US adults.

5 Aug, 2022 | 14:13h | UTC

Experiences of Everyday Ageism and the Health of Older US Adults – JAMA Network Open

Commentaries:

Ageism and health: Study shows close link – Michigan Health Lab

Everyday Ageism Prevalent Among Older U.S. Adults – HealthDay

 

Commentary on Twitter

 


Evidence Synthesis | Deprescribing medicines in older people living with multimorbidity and polypharmacy.

3 Aug, 2022 | 14:20h | UTC

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis – Health Technology Assessment

Related:

Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports

How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative – Journal of Geriatric Oncology

Deprescribing in Palliative Cancer Care – Life

Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360

Process evaluation of implementation strategies to reduce potentially inappropriate medication prescribing in older population: A scoping review – Research in Social and Administrative Pharmacy

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review – Gastroenterology

Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults – JAMA Network Open

The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial – JAMA Internal Medicine

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Deprescribing in palliative patients with cancer: a concise review of tools and guidelines – Supportive Care in Cancer

Prescribing practices, patterns, and potential harms in patients receiving palliative care: A systematic scoping review – Exploratory Research in Clinical and Social Pharmacy

A narrative review of evidence to guide deprescribing among older adults – Journal of General and Family Medicine

Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens – The Lancet Health Longevity

Polypharmacy Management in Older Patients – Mayo Clinic Proceedings

Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy – Deutsches Ärzteblatt international

Eliminating Medication Overload: A National Action Plan – Lown Institute

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action – Drugs & Aging

Common ED Medication Errors: Polypharmacy – emDocs

Current and future perspectives on the management of polypharmacy – BMC Family Practice

Routine deprescribing of chronic medications to combat polypharmacy – Therapeutic Advances in Drug Safety

Polypharmacy—an Upward Trend with Unpredictable Effects – Deutsches Ärzteblatt international

Clinical Consequences of Polypharmacy in Elderly – Expert Opinion on Drug Safety

 


Guideline | Male lower urinary tract symptoms/benign prostatic hyperplasia.

3 Aug, 2022 | 14:17h | UTC

UPDATE – 2022 Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH) – Canadian Urological Association Journal

Related:

AUA Guidelines: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia.

Podcast: LUTS, BPH, and Urinary Incontinence Triple Distilled – The Curbsiders

Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia – Cochrane Library

Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis – Cochrane Library

Phosphodiesterase inhibitors for treatment of urinary problems in men with benign prostatic hyperplasia – Cochrane Library

Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial – The Lancet

 


Guideline | Androgen deprivation therapy: adverse events and management strategies.

3 Aug, 2022 | 14:15h | UTC

UPDATE – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Full-text) – Canadian Urological Association Journal

 


Cohort Study | Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment.

2 Aug, 2022 | 12:26h | UTC

Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment – JAMA Neurology (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Burden of pressure injuries: findings from the Global Burden of Disease study.

1 Aug, 2022 | 12:06h | UTC

Burden of Pressure Injuries: Findings From the Global Burden of Disease Study – Eplasty

 


Comparison of 6 mortality risk scores for prediction of 1-year mortality risk in older adults with multimorbidity.

28 Jul, 2022 | 13:07h | UTC

Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With Multimorbidity – JAMA Network Open

 


Practical Guide | Antihypertensive deprescribing in older adults.

27 Jul, 2022 | 12:23h | UTC

Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports

 


Cohort Study | Fatty liver disease is not associated with increased mortality in the elderly.

25 Jul, 2022 | 12:59h | UTC

Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study – Hepatology

Commentary: Fatty liver disease may not affect mortality risk in elderly patients – ACP Gastroenterology

 


Consensus Recommendations | Screening, diagnosis and management of sarcopenia and frailty in hospitalized older adults.

21 Jul, 2022 | 13:08h | UTC

Screening, Diagnosis and Management of Sarcopenia and Frailty in Hospitalized Older Adults: Recommendations from the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Expert Working Group – The journal of nutrition, health & aging

 


M-A | Costs of multimorbidity.

20 Jul, 2022 | 12:06h | UTC

Costs of multimorbidity: a systematic review and meta-analyses – BMC Medicine

Related:

Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies – BMJ Open

Italian guidelines on management of persons with multimorbidity and polypharmacy – Aging Clinical and Experimental Research

Management of High-Need, High-Cost Patients: A “Best Fit” Framework Synthesis, Realist Review, and Systematic Review – Agency for Healthcare Research and Quality

Designing a High-Performing Health Care System for Patients with Complex Needs: Ten Recommendations for Policymakers – The Commonwealth fund

Effective Care for High-Need Patients: Opportunities for Improving Outcomes, Value, and Health – National Academy of Medicine

Systematic review of high-cost patients’ characteristics and healthcare utilization – BMJ Open

Effectiveness of interventions for managing multiple high-burden chronic diseases in older adults: a systematic review and meta-analysis – Canadian Medical Association Journal

Multimorbidity: a priority for global health research – The Academy of Medical Sciences

The global burden of multiple chronic conditions: A narrative review – Preventive Medicine Reports

Redesigning Care for High-Cost, High-Risk Patients – Harvard Business Review

Multimorbidity: clinical assessment and management – NICE Guideline

Multimorbidity in Older Adults with Cardiovascular Disease – American College of Cardiology, Latest in Cardiology

Richard Smith: The challenge of high need, high cost patients – The BMJ Blogs

Better Care for People with Complex Needs – Institute for Healthcare Improvement

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.